Fluvastatin Sodium
Product Images NDC 68151-1326

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin Sodium (NDC 68151-1326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 1326)

This is a medication called Fluvastatin, produced by Mylan. It is a 20mg capsule with lot number 3045105 and an expiration date of 08/14. The prescription was dispensed on PDM number 1326 and is only available with a prescription.*

FDA Label Image

Fluvastatin Structural Formula (7f4945a8 B0a0 41ec 984c E2a34812bb8b 01)

FDA Label Image

Figure 1: Primary Endpoint (Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population))

FDA Label Image

Figure 2: Fluvastatin Capsules Intervention Prevention Study (Primary and Secondary Endpoints)

FDA Label Image

Figure 3: Change In Minimum Lumen Diameter (mm) (7f4945a8 B0a0 41ec 984c E2a34812bb8b 04)

FDA Label Image

Figure 4: Change In % Diameter Stenosis (7f4945a8 B0a0 41ec 984c E2a34812bb8b 05)

This appears to be a graph or chart showing the change in diameter stenosis due to different therapies. The therapies include monotherapy with olsertamie and combination therapy with fluvastatin and/or CME. The results are shown as percentages, and there are statistical significance levels indicated (p-values). The graph shows that there is a decrease in diameter stenosis for all therapies, but the degree of decrease varies.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.